Skip to main content
Log in

Pharmacodynamics of Trovafloxacin vs Ceftriaxone in Streptococcus pneumoniae

  • Poster Presentations
  • Extended Abstract
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Musher DM. Streptococcus pneumonias. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practices of Infectious Diseases. New York: Churchill Livingston, New York, 1995: 1811–26

    Google Scholar 

  2. Lister PD. Multiply-resistant pneumococcus: therapeutic problems in the management of serious infections. Eur J Clin Micro Infect Dis 1995; 14(1): 18–25

    Article  Google Scholar 

  3. Neu HC, Chin N. In vitro activity of the new fluoroquinolone CP-99,219. Antimicrob Agents Chemother 1994; 38: 2615–22

    Article  PubMed  CAS  Google Scholar 

  4. Lister PD, Sanders WE Jr., Sanders CC. Cefepime-aztreonam: a unique double β-lactam combination for Pseudomonas aeruginosa. Antimicrob Agents Chemother 1998; 42: 1610–9

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lister, P.D., Sanders, C.C. Pharmacodynamics of Trovafloxacin vs Ceftriaxone in Streptococcus pneumoniae . Drugs 58 (Suppl 2), 269–270 (1999). https://doi.org/10.2165/00003495-199958002-00087

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199958002-00087

Navigation